GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA

GE HealthCare aims to advance a new era in theranostics with StarGuide™ GX 4D SPECT/CT, now 510(k) pending with the U.S. FDA

CHICAGO--(BUSINESS WIRE)--Sep 8, 2026-

GE HealthCare Submits New SPECT/CT System for FDA Clearance

GE HealthCare announced that its StarGuide GX digital SPECT/CT system is 510(k) pending with the US Food and Drug Administration.